Scientists from Lancaster University have been enlisted to conduct research as part of a £2m project to develop reusable antiviral and antimicrobial products which could protect against Covid-19.
The team is working with ViraCorp, which is working on a new mask which begins killing Covid-19 on contact. It can be safely reused, offering an alternative PPE solution that has become essential in healthcare businesses where staff are desperate for alternatives.
The university’s research facility will be used for the comprehensive testing of all ViraCorp products. ViraCorp will have full access to the university’s biomedical facilities and equipment including its Containment Level 3 lab facility (CL3) used for the isolation and identification of pathogens.
Dr Muhammad Munir, a virologist and project lead at Lancaster University said: “Collaboration between academia and industry are pivotal in bringing innovations to tackle real-world problems. This unique partnership between Lancaster University and ViraCorp Ltd will bring forward solutions such as antimicrobial PPE to safeguard healthcare workers and the public.”
Rachel Giles, COO of ViraCorp added: “Partnering with Lancaster University is a powerful step for ViraCorp. Their expertise combined with our R&D roadmap will allow us to realise our ambition to create products to help fight infectious diseases facing humanity today.”
- For further Lancashire business news, advice and analysis subscribe to Lancashire Business View or join the LBV Hub from just £2.50 per month. Click here to subscribe now.
Enjoyed this? Read more from Tim Aldred